King of Beiyang

"In just three months, they earned 196 million marks, equivalent to 400,000 taels of silver. It's truly a highly profitable venture!"

Li Jingyuan was very satisfied with the profits he received from the Oriental Pharmaceutical Company.

After all, all he gave up was a sulfanilamide synthesis technique obtained from the future and tens of thousands of marks spent on patent registration.

Moreover, this is only the first dividend distribution.

It is foreseeable that as the pharmaceutical company's production capacity continues to expand, sales will surge. And Li Jingyuan's share of the profits will also increase significantly.

In January of the sixteenth year of the Guangxu Emperor's reign, just after New Year's Day, Jin Kaili found Li Jingyuan and reported the latest situation to him.

"Third Young Master, several well-known pharmaceutical companies in the United States hope to buy out the patents for our new drug in North America."

"Patents in North America? Do you think we need to sell them to them? Or should we sell the new drug there ourselves?" Li Jingyuan asked.

"Third Young Master, with our current production capacity, it will be very difficult to even meet the needs of the European market. It is estimated that we will only be able to initially meet the needs of the European region after the new pharmaceutical plant is completed and put into operation by the end of the year."

Opening up markets in other regions at this time is undoubtedly very difficult. Without sufficient production capacity, we simply cannot supply products.

If they offer a reasonable price, we could sell them the patents in North America.

In this way, the company can quickly obtain a large sum of money.

Jin Kaili analyzed.

Li Jingyuan nodded repeatedly; in fact, he was thinking the same thing.

Although he received a considerable amount of money last year, it's foreseeable that he'll receive even more this year.

However, compared to the funds he needs to purchase warships, build arsenals and shipyards, it is undoubtedly still far from enough.

If one could cash out a large sum of money by selling patents, that would be ideal.

"Do the Hollen family and His Highness the Prince agree? If they have no objections, then let's talk to the Americans! If the price is reasonable, we'll sell them the patent for North America. However, we need to sign an agreement with them that their drugs can only be sold in North America."

Similarly, our medicines will not be sold in North America.

Furthermore, the price they offer must be reasonable.

If they're just hoping to buy our patent license at an extremely low price, they're dreaming!

  

Li Jingyuan reminded him.

Jin Kaili nodded repeatedly, indicating his agreement.

"Third Young Master, I will next inquire with the Hollen family and His Highness the Prince about their opinions. If they have no objections, I will then contact several pharmaceutical companies in the United States."

"Will the Third Young Master attend the meeting?"

Jin Kaili asked.

"It depends. If it's the weekend, I'll participate. Otherwise, I'll pass. After all, I'm still a student, and I have to go to class every day!" Li Jingyuan said helplessly.

Even though he has already given up and given up.

But he must first obtain a degree from Kiel Naval Academy.

In this way, when he returns to China in the future, he will be able to obtain a higher position in the Beiyang Army through Li Hongzhang's efforts.

If he hasn't even gotten his graduation certificate, what right does he have to hold a high position?

Even Li Hongzhang would probably break his legs.

Kim Kye-ri smiled but didn't say anything more.

The Hollen family and Prince Heinrich both agreed to the sale of the patent license for North America.

The market is so big that even after selling the North American market, the remaining market is enough for Oriental Pharmaceuticals to make a fortune.

Moreover, selling patent licenses in the North American market can generate a substantial amount of money.

Several well-known pharmaceutical companies in the United States have long coveted the new drug patents held by Oriental Pharmaceutical Company.

After receiving a response from Oriental Pharmaceutical Company, they immediately dispatched people to Hamburg.

Two weeks later, on the weekend, Lee Kyung-won and Kim Gae-ri met with representatives from Pfizer, Parker Davis, and Wyeth at the headquarters of Orient Pharmaceuticals in Hamburg to discuss patent licensing.

"Gentlemen, it is a pleasure to have you all here at Oriental Pharmaceutical Company. Currently, our company's sulfanilamide sterilization tablets are selling like hotcakes throughout the European market."

The effectiveness of this medicine in sterilization and anti-inflammation has been proven.

We also hope that this medicine can bring hope of health to more patients and save more lives.

Kim Kai-ri got straight to the point, without much small talk.

Perhaps this is the character of the Germans.

"We are very satisfied with the effectiveness of sulfanilamide sterilization tablets. We also hope that people in North America can have access to this new drug, especially when your company's production capacity cannot yet cover the North American region."

"This was stated by Pfizer representative Calvin."

Kim Kai-li nodded; this was undoubtedly a weakness for Eastern Pharmaceutical Company.

"So, gentlemen, how much are you willing to pay to purchase our patent licenses in North America?" Kim Kai-li asked.

Calvin glanced at the telegrams from Parker Davis and James, and Smith, the representative from Wyeth, and then said, "Pfizer is willing to spend two million dollars to buy the patent licenses for North America."

"Two million US dollars?" Kim Kai-ri frowned upon hearing the offer.

Li Jingyuan's expression was equally grim.

Although two million US dollars, which is equivalent to eight million marks at the exchange rate, is not a small sum of money.

But this is far from what they expected.

Or rather, Pfizer is basically giving a beggar a free meal!

"What about Parker Davis and Wyeth?" Kim asked.

"Parker Davis also thinks two million dollars is a very reasonable price!" James replied.

"Yes, two million dollars is a lot!" Smith said.

Now both Kim Kai-ri and Lee Kyung-won knew that these people from the "beacon of the world" were no good.

Although they are competitors, they have clearly colluded to obtain patent licenses in North America at the lowest possible price.

At that time, no matter how they divide the North American market, they will be able to make a fortune.

But the only one who suffered a loss was Oriental Pharmaceutical Company, or rather, Li Jingyuan.

This was undoubtedly unacceptable to Li Jingyuan.

"Gentlemen, in that case, I think we should forget about it. Dongfang Pharmaceutical Company will further expand its pharmaceutical plant and increase production capacity. By the second half of next year at the latest, we will be able to supply medicines to the North American market on a large scale," Li Jingyuan said directly.

Kim Kai-li nodded. Two million dollars was indeed an insult. Oriental Pharmaceuticals would never accept such terms.

Representatives from several North American pharmaceutical companies immediately changed their expressions.

If Eastern Pharmaceuticals refuses to sell patent licenses and instead sells the new drug directly in North America, wouldn't they be watching helplessly as they lose a piece of the pie they've already got their hands on?